Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest antibodies Stories

2013-07-01 12:25:20

DUBLIN, July 1, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zrbgqj/monoclonal) has announced the addition of the "Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion" [http://www.researchandmarkets.com/research/zrbgqj/monoclonal ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...

2013-07-01 12:25:18

DUBLIN, July 1, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zsvknx/competitor) has announced the addition of the "Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies" [http://www.researchandmarkets.com/research/zsvknx/competitor ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report provides a competitor evaluation in the field of recombinant monoclonal...

2013-06-28 20:22:37

TSX: AMF TORONTO, June 28, 2013 /CNW/ - Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for year ended March 31, 2013. "We continue to advance our diagnostic and therapeutic antibody programs and have recently reached a number of critical milestones", said Dr. Robert Gundel, Amorfix President and Chief Executive Officer.  "On the cancer front,...

2013-06-27 08:29:51

SOUTH SAN FRANCISCO, Calif., June 27, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on the status of its ongoing clinical programs for KB003, KB001-A and KB004, its pipeline of proprietary monoclonal antibodies in development for severe respiratory diseases and cancer. (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO) The company announced early completion of enrollment in its ongoing Phase 2 study of KB003, a...

Researchers Link Gluten Antibodies And Autism In Children
2013-06-20 19:11:35

Brett Smith for redOrbit.com — Your Universe Online A group of American researchers has found evidence of gluten antibodies in children with autism, suggesting a potential link between the body immune system and the developmental disorder. The research team also found a connection between elevated antibody levels and gastrointestinal symptoms among affected children. They did not make a connection between elevated antibody levels and celiac disease, according to their report in the...

Inexpensive Blood Test Reveals HPV Presence, Potential Cancer Risk
2013-06-18 18:30:30

Brett Smith for redOrbit.com — Your Universe Online Earlier this month, actor Michael Douglas raised the prospect of oral sex leading to throat cancer through the transmission of the human papillomavirus (HPV), a virus known to cause the disease in some individuals. According to a new study from a team of international researchers in the Journal of Clinical Oncology, blood tests can be used to detect the presence of the virus via the body´s production of telltale antibodies...

2013-06-18 10:32:00

Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils. In their study, at least 1 in 3 individuals with oropharyngeal cancer had antibodies to HPV, compared to fewer than 1 in 100 individuals without cancer.  When present, these antibodies were detectable many years before the onset of disease. These...

2013-06-17 16:25:19

SAN FRANCISCO, June 17, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the appointment of Donald R. Joseph as Chief Legal Officer. Mr. Joseph brings to KaloBios almost 20 years of biopharmaceutical industry experience and has worked in both public and private companies, as well as major global health non-profit organizations. (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO) "Don has a long and successful track record as a general counsel...

2013-06-11 14:59:32

Anti-nicotine vaccination as seen by PET imaging leads to disparity in natural immune response and in some cases can actually increase accumulation of nicotine in the brain Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain. One of the newest studies of a proposed vaccine shows mixed results for...

2013-06-06 23:15:42

“Monoclonal Antibodies Partnering Terms and Agreements” is the new market research report added to the ReportsnReports.com store. Dallas, Texas (PRWEB) June 06, 2013 Monoclonal Antibodies Partnering Terms & Agreements are intended to provide the reader with an in-depth understanding and access to monoclonal antibodies trends and structure of deals entered into by leading companies worldwide. Monoclonal Antibodies Partnering Terms & Agreements...